Trevi Therapeutics Prices $150 Million Offering, Bolstering Funding for Chronic Cough Research
Market Chameleon (Fri, 17-Apr 11:47 AM)
Trevi Therapeutics Raises $150 Million in Public Offering to Advance Chronic Cough Therapy Development
Market Chameleon (Fri, 17-Apr 8:33 AM)
FDA Alignment Paves Clear Path for Trevi’s Phase 3 IPF Chronic Cough Trials—Here Are the Key Takeaways
Market Chameleon (Mon, 9-Mar 9:13 AM)
